Leonard, J. P., Trneny, M., Zhang, H., Nowakowski, G. S., Izutsu, K., Fowler, N., Thieblemont, C., Zinzani, P. L., Gkasiamis, A., Ahn, J. R., Gribben, J. G. (2026). Erratum: Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01085